Document is current
Any future updates will be listed below
-
Authors
Prattichizzo, Francesco
Ceriello, Antonio
- License Information
-
More Information
Article History
Accepted: 29 September 2022
First Online: 5 December 2022
Declarations
:
: F. Prattichizzo: A. Financial interests: honorarium as a speaker or reimbursement of expenses as a passive participant: lecture fees from Berlin-Chemie. B. Nonfinancial interests: researcher, IRCCS MultiMedica. A. Ceriello: A. Financial interests: research funding (personally or at my own disposal): research grants from Mitsubishi. Honorarium as a speaker or reimbursement of expenses as a passive participant: lecture fees from Berlin-Chemie, Eli Lilly, Novo Nordisk, and Roche Diagnostics. Paid consultant/internal training officer/salary earner or similar: advisory board member for Eli Lilly and consultancy fees from Roche Diagnostics, Eli Lilly, and Theras. B. Nonfinancial interests: head of department, IRCCS MultiMedica | Membership: EASD and ESC, President of the executive committee of the D&CVD study group.
: For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.
: The supplement containing this article is not sponsored by industry.
